A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

A Pilot Study to Compare Tretinoin Gel, 0.05% to Tretinoin Gel Vehicle When Dosed Once or Twice Daily in Female Subjects With Classical Rosacea

To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.

Inclusion Criteria:

• Female
• Age 18-65
• Diagnosed with classical, centrofacial, erythemato-telangiectatic rosacea

Exclusion Criteria:

• Male, females less than 18 years
• Females over 65 years
• No diagnosed rosacea